Precipio, Inc. (PRPO) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
Precipio, Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 3826, Laboratory Analytical Instruments, from each company's own filings. Largest first.
PRPO (Precipio, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
High 26.34 at 4:15 am ET, low 26.02 at 11:45 am ET.
Precipio, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Laboratory Analytical Instruments
tall tick = annual report · 1 on record
the bull case· 2
17
managers reporting a position in thirteen F filings
13fJun 30 '26+20.97%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26the bear case· 2
5
managers whose positions together make up four fifths of reported value
13fJun 30 '264 of 11
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 12 '26 report. Not a forecast, not advice.
17 managers report a position worth $3.9M between them, and 5 of them hold 80% of it.